Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
The Pentagon walked back its newly published testosterone screening guidelines for troops — just 24 hours after posting them. The clinical guidance, which outlined mandatory testosterone deficiency screening for service members aged 30 and older, was pulled "to allow for updates," with interim guidance remaining in effect. Doctors had already raised concerns about the policy's scientific basis and potential for unnecessary treatment.
The Pentagon had a quick change of heart. Just one day after publishing detailed clinical guidelines for a mandatory testosterone deficiency screening program for active-duty and reserve service members aged 30 and older, the Department of Defense pulled the document from its website. A U.S. official confirmed the guidance was "temporarily rescinded to allow for updates," with interim guidance remaining in effect in the meantime.
The now-removed guidelines — announced by Defense Secretary Pete Hegseth back in July — laid out separate screening pathways for men and women during annual health assessments. Men 30 and older would have been screened via questionnaire, potentially followed by blood tests and testosterone replacement therapy. Women would have been screened for hormonal imbalance, with testosterone prescribed only for specific evidence-backed conditions like Hypoactive Sexual Desire Disorder.
Key Takeaways:
Why it matters: This rapid reversal highlights the tension between politically driven health mandates and evidence-based medicine. With the FDA's upcoming expert review and ongoing medical pushback, the final shape of this policy — and its implications for military healthcare — remains very much up in the air.
